Natera (NTRA) Competitors $158.36 -10.14 (-6.02%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NTRA vs. FMS, HIMS, RDNT, OPCH, GH, SHC, VCYT, BTSG, LFST, and SGRYShould you be buying Natera stock or one of its competitors? The main competitors of Natera include Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), RadNet (RDNT), Option Care Health (OPCH), Guardant Health (GH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. Natera vs. Fresenius Medical Care Hims & Hers Health RadNet Option Care Health Guardant Health Sotera Health Veracyte BrightSpring Health Services LifeStance Health Group Surgery Partners Fresenius Medical Care (NYSE:FMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, community ranking, dividends, analyst recommendations, institutional ownership, earnings and risk. Which has more risk and volatility, FMS or NTRA? Fresenius Medical Care has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500. Comparatively, Natera has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. Do analysts prefer FMS or NTRA? Fresenius Medical Care currently has a consensus target price of $25.30, suggesting a potential upside of 9.57%. Natera has a consensus target price of $160.63, suggesting a potential upside of 1.43%. Given Fresenius Medical Care's higher possible upside, equities analysts clearly believe Fresenius Medical Care is more favorable than Natera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fresenius Medical Care 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Natera 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in FMS or NTRA? 8.4% of Fresenius Medical Care shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 7.6% of Natera shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer FMS or NTRA? In the previous week, Natera had 15 more articles in the media than Fresenius Medical Care. MarketBeat recorded 15 mentions for Natera and 0 mentions for Fresenius Medical Care. Natera's average media sentiment score of 0.56 beat Fresenius Medical Care's score of 0.00 indicating that Natera is being referred to more favorably in the news media. Company Overall Sentiment Fresenius Medical Care Neutral Natera Positive Is FMS or NTRA more profitable? Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Fresenius Medical Care3.43% 6.04% 2.69% Natera -14.01%-26.23%-14.27% Which has stronger valuation & earnings, FMS or NTRA? Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFresenius Medical Care$19.24B0.70$540.07M$1.2119.08Natera$1.08B19.31-$434.80M-$1.76-89.98 Does the MarketBeat Community prefer FMS or NTRA? Natera received 60 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.96% of users gave Natera an outperform vote while only 54.66% of users gave Fresenius Medical Care an outperform vote. CompanyUnderperformOutperformFresenius Medical CareOutperform Votes42254.66% Underperform Votes35045.34% NateraOutperform Votes48268.96% Underperform Votes21731.04% SummaryNatera beats Fresenius Medical Care on 10 of the 18 factors compared between the two stocks. Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRA vs. The Competition Export to ExcelMetricNateraMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.91B$2.96B$5.21B$9.14BDividend YieldN/A16.02%5.13%4.02%P/E Ratio-89.9815.3489.3417.36Price / Sales19.31200.781,240.0477.11Price / CashN/A426.0143.7535.97Price / Book24.864.925.314.79Net Income-$434.80M-$33.85M$122.54M$225.00M7 Day Performance-6.46%2.81%0.59%2.62%1 Month Performance-2.17%0.53%2.55%3.81%1 Year Performance137.67%15.34%25.29%20.10% Natera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRANatera2.403 of 5 stars$158.36-6.0%$160.63+1.4%+137.7%$20.91B$1.08B-89.983,293Analyst ForecastHigh Trading VolumeFMSFresenius Medical Care3.4425 of 5 stars$22.22-1.2%$25.30+13.9%+18.0%$13.04B$19.24B18.361,358HIMSHims & Hers Health3.5508 of 5 stars$25.52+0.4%$25.13-1.5%+234.2%$5.58B$1.24B58.001,046Short Interest ↑RDNTRadNet4.2693 of 5 stars$66.05-4.0%$84.75+28.3%+58.4%$4.89B$1.77B-943.448,970OPCHOption Care Health4.7478 of 5 stars$27.69+15.4%$29.71+7.3%-9.0%$4.71B$4.78B23.275,600Positive NewsGHGuardant Health3.8987 of 5 stars$37.37+1.8%$40.60+8.6%+57.9%$4.62B$692.26M-8.811,779Short Interest ↓SHCSotera Health3.2821 of 5 stars$13.00-0.8%$16.08+23.7%-13.4%$3.68B$1.12B52.003,000VCYTVeracyte3.9709 of 5 stars$42.45+2.2%$41.13-3.1%+59.0%$3.29B$425.33M-283.00790Analyst UpgradeBTSGBrightSpring Health Services1.4523 of 5 stars$17.20+0.2%$18.65+8.5%N/A$2.99B$10.59B-66.1535,000News CoverageLFSTLifeStance Health Group1.2251 of 5 stars$7.63-1.3%$8.70+14.0%+17.2%$2.92B$1.21B-29.359,325Short Interest ↓Positive NewsSGRYSurgery Partners2.2775 of 5 stars$20.74+0.4%$36.56+76.3%-37.1%$2.64B$2.99B-43.2112,200 Related Companies and Tools Related Companies FMS Competitors HIMS Competitors RDNT Competitors OPCH Competitors GH Competitors SHC Competitors VCYT Competitors BTSG Competitors LFST Competitors SGRY Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NTRA) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NTRA Stock Alerts